back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-07-20 Tx date 2015-05-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,634 vol |
||
| Filed 2016-07-20 Tx date 2015-05-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,634 vol |
0 | |
| Filed 2016-07-20 Tx date 2015-05-22 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,607 vol |
1,607 | |
| Filed 2016-07-20 Tx date 2015-05-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,510 vol |
1,510 | |
| Filed 2016-07-20 Tx date 2015-05-19 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,634 vol |
||
| Filed 2016-07-18 Tx date 2014-10-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-18 Tx date 2014-10-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
Ubben, Jeffrey W.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|